Australia Intravenous Immunoglobulin Market Size & Outlook
The intravenous immunoglobulin market in Australia is expected to reach a projected revenue of US$ 519.0 million by 2030. A compound annual growth rate of 8.4% is expected of Australia intravenous immunoglobulin market from 2024 to 2030.
Revenue, 2023 (US$M)
$294.4
Forecast, 2030 (US$M)
$519.0
CAGR, 2024 - 2030
8.4%
Report Coverage
Australia
Australia intravenous immunoglobulin market, 2018-2030 (US$M)
Related Markets
Australia intravenous immunoglobulin market highlights
- The Australia intravenous immunoglobulin market generated a revenue of USD 294.4 million in 2023 and is expected to reach USD 519.0 million by 2030.
- The Australia market is expected to grow at a CAGR of 8.4% from 2024 to 2030.
- In terms of segment, immunodeficiency diseases was the largest revenue generating application in 2023.
- Kawasaki Disease is the most lucrative application segment registering the fastest growth during the forecast period.
Intravenous immunoglobulin market data book summary
| Market revenue in 2023 | USD 294.4 million |
| Market revenue in 2030 | USD 519.0 million |
| Growth rate | 8.4% (CAGR from 2023 to 2030) |
| Largest segment | Immunodeficiency diseases |
| Fastest growing segment | Kawasaki Disease |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Immunodeficiency diseases, CIDP, Hypogammaglobulinemia, Congenital AIDS, Chronic Lymphocytic Leukemia, Myasthenia Gravis, Multifocal Motor Neuropathy, ITP, Kawasaki Disease, Guillain-Barre Syndrome |
| Key market players worldwide | Biotest AG ADR, Baxter International Inc, Grifols SA Ordinary Shares - Class A, CSL Ltd, Octapharma AG, LFB (Laboratoire Français du Fractionnement et des Biotechnologies), Taibang Biological Group, Kedrion Biopharma |
Other key industry trends
- In terms of revenue, Australia accounted for 2.3% of the global intravenous immunoglobulin market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan intravenous immunoglobulin market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,078.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Intravenous Immunoglobulin Market Scope
Intravenous immunoglobulin market segmentation & scope
Immunodeficiency diseases
CIDP
Hypogammaglobulinemia
Congenital AIDS
Chronic Lymphocytic Leukemia
Myasthenia Gravis
Multifocal Motor Neuropathy
ITP
Kawasaki Disease
Guillain-Barre Syndrome
Others
Intravenous Immunoglobulin Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia intravenous immunoglobulin market size, by application, 2018-2030 (US$M)
Australia Intravenous Immunoglobulin Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
